ArticleDiabetology & metabolic syndrome2023

Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients.

Ran Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.